ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

MITRA Mithra Pharmaceuticals SA

0.216
0.00 (0.00%)
Last Updated: 05:42:45
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Mithra Pharmaceuticals SA MITRA Euronext Ordinary Share
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 0.216 05:42:45
Open Price Low Price High Price Close Price Prev Close
0.216
more quote information »

Recent News

Date Time Source Heading
5/28/202409:41GLOBEMithra postpones its annual general meeting
5/03/202411:30GLOBEMithra enters into exclusive negotiations with Gedeon..
4/29/202401:00GLOBEMithra updates on offers received in the context of its..
4/22/202401:00GLOBEMithra secures court protection measures to advance..
3/08/202401:00GLOBEMithra reports full year 2023 financial results
3/05/202401:01GLOBEMithra announces changes to its executive management
3/05/202401:00GLOBEMithra initiates monetization process, receives bridge loan..
2/29/202405:42GLOBEDONESTA® safety study for menopause completes treatment..
2/15/202412:23GLOBEMithra sells shares in Mayne Pharma
2/06/202401:00GLOBEMithra updates on cash position
12/21/202311:45GLOBEMithra and Rafa Laboratories sign binding Head of Terms to..
12/20/202311:45GLOBEMithra Completes Pediatric Study of ESTELLE® in Adolescent..
12/18/202301:00GLOBEMithra Receives Positive DSMB Opinion on DONESTA® European..
12/04/202301:00GLOBEMithra and Gedeon Richter sign binding Head of Terms to..
11/30/202301:00GLOBEMithra receives guidance from the FDA for the DONESTA® NDA..
11/28/202311:45GLOBEMithra to hold five presentations on key role of estrogens..
11/07/202301:00GLOBEMithra’s NEXTSTELLIS® granted additional patent in the..
11/06/202312:52GLOBEMithra releases invitation to its extraordinary securities..
10/26/202301:00GLOBEMithra and Searchlight Pharma sign DONESTA® licensing..
10/23/202301:00GLOBEMithra to receive EUR 2.5 million milestone payment from..
10/17/202301:00GLOBEMithra’s Board of Directors to propose the removal of its..
10/11/202301:15GLOBEShareholder Letter
10/11/202301:00GLOBEMithra announces update to the agenda of its upcoming..
10/10/202312:00GLOBEMithra to Hold Presentations on Key Role of Estrogens in..
10/05/202301:00GLOBEMithra Provides an Update in the Context of Recent Market..
9/27/202301:00GLOBEMithra Announces Presentation of Positive Data on Estetrol..
9/26/202301:00GLOBEMithra Financial Results for First-Half 2023
9/22/202307:30GLOBEMithra présentera ses résultats financiers du premier..
9/21/202311:55GLOBEMithra to Hold Investor Call on H1 2023 Financial Results on..
9/12/202311:45GLOBEPublication of a Transparency Notification Received from..
9/11/202301:30GLOBELetter to Shareholders and Corporate Update
8/28/202311:45GLOBEMithra completes EUR 20 million private placement in equity..
8/24/202301:33GLOBEMithra prices private placement to raise EUR 20 million in..
8/08/202301:30GLOBEMithra and Gedeon Richter Sign Supply Agreement for..
8/03/202301:30GLOBEMithra Receives EUR 1.25 Million Milestone Payment from Fuji..
7/31/202301:30GLOBEMithra and Searchlight Pharma Announce Donesta® Licensing..
7/17/202311:45GLOBENotice of Adjustment of the Conversion Price of Mithra's..
7/04/202311:45GLOBENotice of Adjustment of the Conversion Price of Mithra's EUR..
6/26/202311:45GLOBEMithra Announces Information on the Total Number of Voting..
6/21/202314:38GLOBEMithra has access to the new EUR 12.5 million tranche of the..
6/15/202301:30GLOBEMithra Announces New Positive Preclinical Data from CSF-1R..

Your Recent History

Delayed Upgrade Clock